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Summary.-The depression of the immunological status of BALB/c mice treated
during infancy with two different doses of urethane, alone or combined with corti-
sone, was evaluated by counting the number of plaque forming cells at 30 or 50 days
of age. The incidence of lung adenomatous nodules was directly related to the
degree of immunological impairment at 50 days of age. Twenty-seven lung adeno-
mata were tested in an in vitro system involving spleen cells immune against the
same single tumour used as target cell. Eighty-six per cent of tumours in the most
immunodepressed group of mice were positive compared with 20 40%o in the less
immunodepressed groups. Syngeneic cross-reaction tests showed that non-
immunogenic tumours were immunosensitive since66%o positive tests were obtained
when target cells belonging to the less immunodepressed groups were tested with
spleen cells of mice immunized with immunogenic adenomata.
WE have previously reported(Colnaghi,
Menard and Della Porta, 1971) that lung
adenomata induced by urethane in mice
could elicit in the syngeneic host into
which they were transplanted an immuno-
logical response detectable in vitro by
meains of a microassay for cell mediated
immunity. The detected antigens were
cross-reacting and were found only in
tumours that arose in mice that were
given an inmmunodepressive treatment con-
currently with urethane. Immunizations
were carried out with pooled tumour
tissues, which procedure has been
found to favour the demonstration of
cross-reacting antigens in chemically-
induced tumours (Reiner and Southam,
1969).
The present experiments were designed
to extend the previous ones to include a
comparative study of the immunogenicity
of pooled versus individual lung adeno-
mata, and the evaluation of the influence
of the level of immunodepression on the
23
incidence of lung adenomatous nodules
and on their antigenicity.
MATERIALS AND METHODS
Animal8.-BALB/c mice were used, of
both sexes, maintained in this laboratory by
brother x sister mating.
Tumours.-Lung adenomata were induced
by 5 i.p. injections of urethane 0-2 or 1 mg/g
body weight once every second day, starting
at 10 days of age (Group A and B). Two
other groups of mice (C and D) received the
same urethane treatment and in addition,
on alternate days, 5 injections of 0-1 mg/g
body weight of cortisone. The mice were
killed when they showed symptoms of
dyspnea, their lungs were dissected and the
number of adenomatous nodules counted.
Plaque-forming cells determination.-The
number of spleen plaque forming cells (PFC)
was determined following the Jerne technique
(Jerne, Nordin and Henry, 1963). Four
days after an i.p. injection of a sheep red
blood cell 500 suspension (v/v) in 0-25 ml of
saline, 4 animals pergroup were killed and theS. MENARD, M. I. COLNAGHI AND G. CORNALBA
TABLE I.-Cytotoxic Effect of Syngeneic Immune Spleen Lymphoid Cells on Urethane-
Induced Lung Adenomata ofBALB/c Mice. Illustration of a Typical Experiment
on Target Cells No. 28 of Group D
Number of adenoma Number of adenoma
cells after incubation cells after incubation Percentage
Immunizing Number of with normal lymphocytes with test lymphocytes of
adenoma replicates (mean ± s.e.) (mean ± s.e.) reduction P<
,-28 16
D-11 16
B-25 16
C-20 16
A-35 14
* Not significant
214± 16
214± 16
214± 16
214± 16
214± 16
139±10
134± 10
202±13
230±18
209±16
35
37
5
2
0-001
0*001
*
TABLE II.-Effect on Spleen Plaque-forming Cells ofFive Doses of Urethane Alone or in
Combination with Cortisone Administered during Infancy to BALB/c Mice
Treatment
Urethane Cortisone
Untreated
Group A
Group B
Group C
Group D
0-2 mg/gx5
1 mg/gx5
0 2 mg/g x 5 0*1 mg/g x 5
1 mg/g x 5 0O1 mg/gx 5
Untreated
Group A 0 2 mg/gx5
Group B 1 mg/g x 5
Group C 0 2 mg/g x 5 0O1 mg/g x 5
Group D I mg/g x 5 01 mg/g x 5
* Four animals per group.
Age at
test
(days)
30
30
30
30
30
50
50
50
50
50
Spleen
weight
(mg)
(mean±s.e.)*
130± 4
122± 5
85± 6
95± 6
77± 5
173±15
120±15
143± 12
100± 6
123± 4
PFC/106
nucleated
spleen cells
(mean±s.e.)*
540±22
302±47
35± 6
77±25
3± 1
546±40
364±38
303±28
264±22
175±18
Percentage
of
reduction
44
93
86
99
34
45
52
68
0.01
0*001
0*001
0*001
0*01
0.001
0*001
0-001
spleensremovedandweighed. Thenucleated
cells of each spleen were counted and then
processed for PFC determination on agar
plates. Threeplateswerepreparedfromeach
spleen.
Immunization and cytotoxic test.-Single
adenomatous nodules were removed from
lungs and minced in TC 199 medium to
obtain a cell suspension, 0-2 ml of which,
containing 1 x 106 living cells, was injected
s.c. into 2-month old BALB/c mice of the
same sex as the tumour donor. When the
subcutaneous tumours had grown to about
10 mm in diameter the animals were operated
to remove tumour tissue and cell suspensions
were prepared aseptically in medium TC 199
with 20% foetal calf serum, 100 i.u./ml
penicillin and 100 ug/ml streptomycin.
About 500 viable cells were then directly
seeded in tissue culture plastic microplates
(No. 3034 Falcon Plastics, Los Angeles,
California, U.S.A.) and allowed to attach at
370C in a 5% C02 humidified atmosphere.
Four days later the plates were washed once,
refilled with fresh mediumandincubated for a
further 3 days. Then the microplates were
washed and 5 x 104 viable lymphocytes in
10 ul medium were delivered into each well
where 300-500 tumour target cells were
found. The effector cell suspensions were
obtained from spleens of tumour or sham.
operated animals by purification with the
Ficoll-Triosil method (Harris and Ukaejiofo,
1969) and contained at least 80% lympho-
cytic cells. After 48 hours' incubation the
microplates were washed carefully with
balanced salt solution to remove lymphoid
and dead cells, and viable attached cells were
fixed in methanol and stained with May-
Grunwald-Giemsa. Counting was carried
out under the microscope with the help of a
25 square grid covering the entire floor ofthe
well except the margins, and taking into
consideration only epithelial-like cells present
in 10 squares per well. The significance of
the difference between the adenoma cell
number after exposure to experimental or
control effector cells was evaluated by
Student's t test. Differences were considered
significant when P was 0-01 or less.
The results ofa typical experiment on one
ofthe target cells are reported in Table I.
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RESULTS
Immunological impairment
As shown in Table II, the treatment
during infancy with the high dose of
urethane (Group B) or with urethane at
either dose and cortisone (Group C and
D) reduced the number ofPFC at 30 days
of age to 90% of the number in the
untreated controls, whereas the low dose
of urethane alone (Group A) gave a 44%
reduction.
At 50 days of age the percentage
reduction of PFC, although less marked,
was still significant in all groups. The
reduction was significantly greater in each
ofthe 2 groups treated with urethane and
cortisone than in the corresponding group
treated with urethane alone.
Relationwhip between the immunological
impairment and the number of tumours in
the lungs
The animals were killed when symp-
toms of dyspnea were evident at a mean
age of 57 ± 2,56 + 2,55±3 and 47 ± 2
weeks in the A, B, C and D group respec-
tively. The average numbers of adeno-
matous nodules per mouse in the groups
treated with either doses of carcinogen
alone (3.2 ± 0 5 in Group A and 4*2 ±
0-5 in Group B) and those in the corres-
ponding groups treated with cortisone in
addition to the carcinogen (5.2 ± 0-8 in
Group C and 7 0 ± 0-6 in Group D) were
significantly different (P < 0 05 and P <
0-001 for the groups treated with the low
andthehighdose ofurethanerespectively).
As shown in Fig. 1, the number of
adenomatous nodules was directly related
to the immunological impairment evalu-
ated at 50 days of age and not to the
higher dose ofthe carcinogen.
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FIG. 1.-4Aelationship between the number of
adenomatous nodules per lung and immu-
nodepression evaluated as PFC reduction
at 50 days of age, in mice treated during
infancy with 5 doses of urethane, 0 2 mg
or 1 mg/g bodyweight, alone (Group Aand
B) or combined with 5 doses of 0 1 mg/g
body weight of cortisone (Group C and D).
TABLE III.-Immunogenicity and Immunosensitivity of Urethane-induced
Lung Adenomata ofBALB/c Mice
Number of positive tests/Total number of tests
e
Effector cells
Immune against
individual tumours of
Group A
Group B
Group C
Group D
Immune against pool
of 6 tumours of
Group A+B+C
Autochthonous tests
Target cells from same
tumours used to immunize
2/10
1/5
2/5
6/7
Cross-reaction tests
Target cells from tumours of Group
A B 0 D
2/8
0/6
3/5
1/6
1/6
2/3
0/2
1/3
5/7
2/8
0/3
2/7
6/8
1/6 1/2 2/4 3/4 10/16
Total
3/16
3/14
3/19
16/23
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lImimunogenicity and immunosensitivity of
tumours
A total of 27 lung adenomata were
tested with autochthonous and syngeneic
effector cells (Table III). In the direct
system, involving lymphocytes immune
against the same tumour cells used as
target, Group D treated with the high dose
of urlethane and cortisone yielded 86%
positive tests, whereas Group B, which
had the same dose of carcinogen without
the immunodepressor, had only 20%
positive tests. With the low dose of
urethane, 4000 of the tests were positive
in Group C, which had cortisone also,
compare(1 with 200o in Group A, which
had the same dose of carcinogen without
cortisone.
To search for cross-reacting antigens
and to study the immunosensitivity of the
tutmours, syngeneic cross-reaction tests
were carried ouit in which the 27 lung
adenomata studied in the autochthonous
system were tested with spleen cells
immune against different single tumours
of the 4 groups. On several occasions the
same target cells were tested with 2 or
more preparations. The tests with spleen
cells anti-Group D tumours confirmed the
antigenicity of these tumours since 750o
of the tests performed on Group D target
cells were positive, and revealed also that
tumours of the other groups, which had
been negative in the autochthonous test,
were immunosensitive. In fact, consider-
ing the target cells of the A, B and C
groups together, which behaved similarly
as regards their antigenicity, only 25% of
tests were positive in the autochthonous
system whereas 66% were positive when
the effector cells were from animals
immunized against Group D tumours.
In contrast, spleen cells sensitized
against individual tumours of Group A,
13 and C gave 78% negative tests on the
lung adenomata of Group D, previously
demonstrated to be antigenic, and were
only occasionally positive on tumours of
the other groups. The difference in
activity between spleen cells sensitized
against Group D tumours (16 positive
tests out of 23) or against tumours from
A, B and C groups (9 positive tests out of
49) was highly significant (P < 0.001) as
analysed by the x2 test.
Six tumours found to be non-immuno-
genic, 2 from each of CGroup A, B3 and C
were used at the secoind transplant passage
to immunize as a pool. The sensitized
spleen cells were tested oIn tumours of all
groups and found cytotoxic on 7500 of
target cells of Group D, 50°/ of Group B
and C and 66% of Group A. Ten tests
out of 16 were positive compared to 9 out
of 49 positive tests found wlhen tumours
from the same A, B and C groups were
used to immunize singly (P < 0-001).
I)ISCUSSION
The results of these experimleints, in
agreement with other reports (Trainin aind
Linker-Israeli, 1970; Della Porta, Colnaghi
and Parmi, 1970; Lappe6 and Prehn,
1970), indicated that the incidence of
pulmonary adenomatous nodules induced
in mice by urethane depended oIn the
immunological environment in which the
primary tumours arose. In the most
immunodepressed animals the number of
nodules per lung and the number of
immunogenic tumours were significantly
higher than in the groups which at 50
days of age showed a better immuno-
logical recovery. When the primary tu-
mour hosts were strongly immunode-
pressed all but one of the tumours were
immunogenic, whereas only 25% of the
tumours from the other less immuno-
depressed groups were able to immunize.
However, when the lung adenomata
beJonging to these last groups were tested
for their immunosensitivity with proper
effector cells, 660/ were found positive.
This suggests that tumour associated
antigens might be present on the cell
membrane of all lung adenomata but in
different quantities and that the quantita-
tive expression was related to the level of
immunocompetence ofthe primary tumour
hosts. The immunocompetent animals,
by an immunoselective process, seem to
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have favoured the growth of cells with a,
low antigen density. Only tumours with
a high antigen density were immunogenic,
but tumours with a low antigen expression
could be immunosensitive.
Alternatively, it could be argued that
all the tumours were equally antigenic
but that the immune pressure in the less
immunodepressed host had determined an
in vivo modulation of the tumour specific
antigens (Joachim et al., 1972; Aoki and
Johnson, 1972) which could reappear
during the in vitro culture before the test.
In our previous report (Colnaghi et al.,
1971) the immunization was carried out
with pools of tumours whereas in the
present work, in all the experiments but
one, single tumours were used to verify
whether the detection of lutng adenoma
antigenicity, which had not been found by
other authors in in vivo experiments
(Prehn, 1965; Pasternak, Hoffmann and
Graffi, 1 966), was related to the immuniz-
ing proceduire. Also, individtual nodules
were shown to be immonogenic when the
lung adenomata arose in the strongly
immunologically impaired groups, con-
firming that the immunological status of
the host is a major factor conditioning the
immunogenic strength of lung adenoma.
However, when selected non-immuno-
genic primary tumours were used at the
second transplant passage to immunize,
and 6 tumours were pooled together, a
detectable immune response was induced.
The tumour-associated antigen(s), per-
haps, were modulated in the less immuno-
depressed primary hosts and reappeared
in the subsequent transplant, augmenting
the antigenic expression to a level able to
render the tumours immunogenic as well.
Unfortunately not enough material was
available to enable Us to perform the single
immunization test in parallel.
G-virus related antigens have been
reported to be present on chemically
induced sarcomata (Old and Boyse, 1965;
Whitmire et al., 1971). A viral involve-
ment seems to be suggested by the fact
that 3 lung adenomata tested for the
presence of group-specific antigens of
murine leukaemia virus were found to be
positive (unpublished results) and that
viralparticleshaveoccasionallybeen found
in murine lung adenoma (Brooks, 1970;
Bucciarelli, 1971). We do not know.
however, whether a complete viral ex-
pression is present in our lung adenomata,
including virus-induced cell membrane
antigens able to elicit the cell-mediated
cvtotoxic activity we have found. On the
other hand, cross-reacting antigens of the
embryonic type have also been found in
chemically induced tumours (Baldwin,
Glaves and Vose, 1972; Colnaghi and
Della Porta, 1973; Menard, Colnaghi and
Della Porta, 1973) and we cannot exclude
that antigens of this type could have
determined the lung adenoma antigenicity.
Experiments to elucidate this point are in
progress.
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